The role of exosomes as oligonucleotide delivery system for managing α-synuclein in Parkinson's disease: A systematic review of in vivo studies
{{output}}
Although Parkinson's disease (PD) is primarily idiopathic, genetic mutations-accounting for approximately 5%-15% of cases with regional variability-have prompted the development of gene expression modulators, such as oligonucleotides, to target and reduce alp... ...
